Weight-loss drug developer Metsera, backed by ARCH Venture Partners, revealed a wider loss in its paperwork for a U.S.

Metsera has filed for an initial public offering. The clinical-stage biopharmaceutical company submitted a registration statement to regulators on Friday, saying it intends to list under the ticker ...

Online furniture retailer Wayfair said on Friday it would lay off 730 employees as it exits the German market to focus on ...

The U.S. government on Friday proposed 2026 reimbursement rates for Medicare Advantage plans run by private insurers that ...

Metsera files for IPO, developing GLP-1 drug MET-097i and other obesity treatments to compete with Eli Lilly and Novo Nordisk ...

Energy equipment and services provider Flowco launched the year’s first major IPO, planning to raise $392 million and list in ...

The round is one of Europe’s largest-ever biotech VC deals, signalling investor appetite for the booming weight loss market.

President-elect Donald Trump is a week and a half away from inheriting a strong economy from President Joe Biden. Yahoo ...

Whether you’re a fan of the All Blacks, a follower of the women’s game or someone who watches every phase of play in the Premiership, our rugby features and news pieces will provide you with all of ...